PER
Click for more information
3.70% 8.4¢ percheron therapeutics limited

I highly doubt that - any continued dosing from Phase IIb for...

  1. Akki
    35,672 Posts.
    lightbulb Created with Sketch. 548
    clock Created with Sketch.
    20/01/20
    16:33
    Post #: 42476818
    I highly doubt that - any continued dosing from Phase IIb for participants post their trial if they decide to continue it in 18-24 months time would be separated the data wouldn't be released until after completion of the trial. It would just make the trial messy it would be under a separate protocol. I'd also assume it wont be a straight continuation as with the last trial the last time point measured is 4 & 8 week post treatment.
    ANP Price at posting: 7.4¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
0.003(3.70%) 		Mkt cap ! $75.73M
Open High Low Value Volume
8.1¢ 8.4¢ 8.1¢ $79.19K 960.1K

Buyers (Bids)

No. Vol. Price($)
1 100200 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 114242 2
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.